Gut Bacteria Link Mental Health and Skin Conditions Through Shared Pathways

Mental health disorders frequently co-occur with skin conditions, but the biological mechanisms underlying this connection have remained unclear. This review synthesizes evidence for a gut-brain-skin axis where microbiome disruption serves as a shared pathogenic factor linking neuropsychiatric and dermatological disorders.

Researchers examined gut microbiota patterns across autism spectrum disorder, depression, anxiety, and schizophrenia, alongside their common skin comorbidities including atopic dermatitis, psoriasis, and rosacea. Consistent microbial alterations emerged across both domains: reduced alpha diversity, disrupted Firmicutes/Bacteroidetes ratios, and depletion of beneficial short-chain fatty acid-producing bacteria like Faecalibacterium, Roseburia, and Eubacterium species.

These microbial shifts parallel elevated inflammatory markers including IL-6, TNF-α, IL-1β, and IL-17 in both psychiatric and skin conditions. The dysbiosis also disrupts amino acid metabolism, particularly affecting glutamate-GABA signaling pathways crucial for brain function, while increasing branched-chain amino acids that promote inflammation.

Animal studies support this connection, demonstrating that induced gut dysbiosis can simultaneously trigger psychiatric-like behaviors and skin inflammation. Conversely, probiotic interventions show preliminary efficacy in improving symptoms across both domains, suggesting therapeutic potential for targeting the microbiome.

This integrated model offers new treatment possibilities. Rather than addressing mental health and skin conditions separately, targeting gut dysbiosis may provide a unified approach to managing both psychiatric symptoms and dermatological comorbidities through restoration of microbial balance and reduction of systemic inflammation.